StonvexLoading…
StonvexStonvexStonvexCore line items from COO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $1.02B | $4.09B | $3.03B | $1.97B |
Operating Income | $212.80M | $682.90M | $542.50M | $366.80M |
Net Income | $130.80M | $374.90M | $290.30M | $87.70M |
EPS (Diluted) | $0.66 | $1.87 | $1.45 | $0.96 |
Total Assets | $12.42B | $12.39B | $12.38B | $12.41B |
Total Liabilities | $4.06B | $4.16B | $4.02B | $4.13B |
Cash & Equivalents | $124.90M | $110.60M | $124.90M | $116.20M |
Free Cash Flow OCF − CapEx | $158.70M | $433.70M | $283.80M | $119.30M |
Shares Outstanding | 195.10M | 195.90M | 198.80M | 199.50M |